Low-Dose Atropine: Beyond Refraction - Poll - MDSpire

Low-Dose Atropine: Beyond Refraction

Why clinical trial endpoints and dosing strategies should evolve in myopia control

  • By

  • Hakan Kaymak

  • Carla Lança

  • Andrzej Grzybowski

  • June 24, 2026

  • 9 min

Share

Original Source(s)

Low-Dose Atropine: Beyond Refraction

  • by Hakan Kaymak, Carla Lança, Andrzej Grzybowski

  • June 24, 2026

Related Content

FOXC1 Duplications Linked to Early-Onset Glaucoma

FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.

Belzutifan-induced tumor regression in sporadic hemangioblastoma: a case report and literature review

Disseminated cystic echinococcosis presenting as orbital swelling in a child — case report and literature review